coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Chaw (chelford, Handforth, Alderley Edge, Wilmslow) PCN, Cheshire East (LAD) · Health Inequalities Profile

    PCN U31094 · NHS Cheshire and Merseyside Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    52,399

    Registered population

    57.6% aged 18–64

    22.9%

    Aged 65+

    ICB 19.0% · England 17.9%

    9.6%

    Ethnic minority (non-White)

    4.9% Asian · England 9.6%

    3.9%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~1,911

    Core20 residents (est.)

    Resident basis; registered basis ~2,033 · see page 3

    8,243

    Hypertension register

    +6.27% in 3 yrs · England +5.60%

    398

    SMI register

    10% of Cheshire East (LAD)'s

    663

    COPD register

    Reviews -5.15% in 3 yrs

    Forecast to 2030

    9,835

    Hypertension patients, 2030

    +1,592 on today

    70.2%

    QRISK ≥20% on statins, 2030

    +3.09pp over 3 yrs

    6.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -6.0%
    Asthma review coverage fell behind England.

    Asthma reviews fell 6.0% over 2023 to 2025 to 61.2% (England +4.4% to 65.7%), leaving 1,214 register patients unreviewed; a recall audit would test.

    5.2 pp
    Pre-school MMR2 and booster coverage gaps.

    In Q1 2025/26, age-5 MMR2 (91.1%) trails MMR1 (96.3%) by 5.2 pp and 4-in-1 is 86.7% against the 95.0% target, possibly reflecting unverified recall.

    85.2%
    Heart failure, hypertension and diabetes control exceed England.

    Heart failure reviews reach 85.2% (England 78.5%), hypertension treatment to target 70.8% (England 70.3%) and non-frail diabetes HbA1c control 59.7% (England 57.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 22.9% of patients across six practices alongside 20 care homes

    Across six practices with 52,399 registered patients, 22.9% (11,972 patients) are aged 65+, above Cheshire East (22.6%), the ICB (19.0%) and England (17.9%). The non-White resident share is 9.6%, with Asian or Asian British residents at 4.9% (LAD 2.4%, ICB 2.8%, England 9.6%), peaking at 7.8% around Handforth Health Centre. White residents comprise 90.4% (LAD 94.4%, ICB 93.0%, England 81.1%). An unverified projection indicates 4.1% list growth to 2030 (LAD 3.4%, ICB 2.3%, England 2.3%). Ethnicity figures reflect Census usual residents rather than GP registrations, while age bands reflect registered lists.

    Age profile

    0–1719.5%
    18–6457.6%
    65+22.9%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White90.4%
    Asian4.9%
    Mixed2.7%
    Other1.4%
    Black0.6%

    Older people · falls rows are Cheshire East (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire East LA)2,1292,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire East LA)9391,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire East LA)14.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low at PCN decile 8.4 but concentrated in two practices

    Average IMD decile is 8.4, above Cheshire East (7.1), the ICB (5.2) and England (5.5). Registered Core20 share is 3.9%, below Cheshire East (9.2%), the ICB (31.9%) and England (21.0%). Deprivation is concentrated in two practices: Handforth Health Centre has a 14.4% share (1,496 estimated patients) and Wilmslow Health Centre has 3.2% (537 estimated patients). Resident LSOA estimates identify 1,911 people in deciles 1 and 2, differing from practice-modelled totals (2,033). Outreach should prioritise Handforth Health Centre for concentration and Wilmslow Health Centre for volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Handforth14.4% · 1,496 patients
    Wilmslow3.2% · 537 patients
    Kenmore0.0% · 0 patients
    Alderley Edge0.0% · 0 patients
    Chelford0.0% · 0 patients
    David Lewis0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    398

    SMI register

    0.76% recorded prevalence

    279

    Learning disability register

    0.53% recorded prevalence

    20

    Care homes, 1,247 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Cheshire East (LAD), Census 2021

    The PCN records 279 learning disability patients (0.5% prevalence; LAD 0.5%, ICB 0.6%, England 0.6%) and 398 severe mental illness patients (0.8%; LAD 0.9%, ICB 1.1%, England 1.0%). Catchments include 20 care homes with 1,247 beds, though beds do not establish resident occupancy. While crude prevalence does not establish unmet need, annual physical health checks support routine monitoring for registered cohorts.

    Severe mental illness: physical health checks

    SMI blood pressure checks fell 3.4 pp over 2023 to 2025 to 78.0% (England +4.4 pp to 83.4%), while alcohol recording was 71.9% (England 81.8%). Across 398 SMI patients, this is consistent with unverified annual review gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,243

    Hypertension register

    +6.27%

    Register growth, 3 yrs

    Cheshire East (LAD) +6.54% · England +5.60%

    +0.47pp

    BP control, under 80

    ≤140/90 · −2.30pp aged 80+

    +1,592

    More patients by 2030

    Forecast 9,835 (17.72%)

    Hypertension case-finding and control

    Hypertension prevalence is 15.7% (8,243 patients), above England (15.2%) but below Cheshire East (17.3%) and the ICB (16.8%), though crude rates are not age-adjusted. While 90.3% had a recent blood pressure check (England 90.0%) and overall treatment to target is 70.8% (England 70.3%), control in patients aged 80+ fell 2.8% over 2023 to 2025 (England +2.2%) to 79.9% (England 81.2%). This drop could reflect unverified follow-up delays or prescribing differences. Older hypertensive patients trail national control benchmarks, so the PCN should prioritise targeted medication reviews and home blood pressure monitoring for patients aged 80 and over.

    Lipids and statins

    Statin treatment for diabetes primary prevention is 69.8%, trailing England (73.2%), Cheshire East (71.0%) and the ICB (72.4%). Secondary prevention reaches 83.2% (England 84.4%). Lower primary-prevention statin coverage leaves diabetic patients under-protected, indicating an opportunity to prioritise routine statin initiation audits in diabetes reviews.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026100,423£1.90£1.71£1.86£190,804
    Cardiovascular (all), 2025127,283£4.23£4.37£3.33£538,407

    In 2026, the PCN prescribed 100,423 lipid-regulating items at £1.90 per item, above England (£1.86), Cheshire East (£1.72) and the ICB (£1.71). Across these items, the PCN spends £4,017 more than at England's unit cost. Higher unit costs on lipid-regulating items suggest an opportunity to review formulary adherence and switch to lower-cost statin options.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.99%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.36%

    Asthma prevalence, PCN 3-yr % change

    Over 2023 to 2025, asthma annual reviews fell 6.0% to 61.2% (England +4.4% to 65.7%), leaving an estimated 1,214 of 3,131 register patients unreviewed. COPD reviews fell 5.2% to 75.0% across 663 patients (England +2.8% to 76.4%). Asthma prevalence is 6.3% (England 6.6%) and COPD is 1.3% (England 1.9%). Slower review delivery, alongside second-hand smoking recording at 73.5% (England 78.8%), may reflect recall backlogs rather than lower clinical need.

    Cancer register and children's immunisation

    Cancer recorded prevalence is 5.2% (2,754 patients; England 3.8%). In Q1 2025/26, childhood coverage trailed the 95.0% target: 6-in-1 at 12 months was 87.3% and MMR1 at 24 months was 88.3%. At age 5, MMR1 was 96.3% but MMR2 trailed by 5.2 pp at 91.1% across 135 children, while 4-in-1 was 86.7%, consistent with unverified pre-school recall gaps.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months87.3%

    England 91.0%

    6-in-1 complete primary course at 24 months93.2%

    England 92.2%

    MMR dose 1 at 24 months88.3%

    England 88.3%

    MMR dose 2 at age 591.1%

    England 82.8%

    4-in-1 pre-school booster at age 586.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of staged cancers (7,482 of 13,490) in NHS Cheshire and Merseyside ICB were diagnosed at stage 1 or 2, against 55.3% in England, remaining below the 75.0% national ambition by 2028 by 19.5 pp. Staging completeness was 72.8% (13,490 of 18,522 registered cases). Between 2013 and 2022, early-stage diagnosis increased by +2.6 pp across the ICB, requiring about 2,640 additional early diagnoses annually to achieve the ambition. System performance reflects wider ICB delivery rather than PCN delivery. Primary care screening records show PCN breast screening at 74.2% and cervical screening at 71.9%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Manchester University NHS Foundation Trust achieved 80.1% on the 28-day faster diagnosis standard (East Cheshire NHS Trust 81.1%, Stockport NHS Foundation Trust 83.2%, ICB 77.2%, England 79.3%), exceeding the 75.0% standard. However, 62-day referral to treatment was 72.8%, falling below the 85.0% standard by 12.2 pp (East Cheshire NHS Trust 53.4%, Stockport NHS Foundation Trust 74.7%, ICB 76.2%, England 71.2%). Diagnostic 6+ week waits were 14.7% for CT (England 9.9%) and 11.7% for MRI (England 21.4%). Hospital waiting times reflect provider performance rather than PCN delivery.

    Pathways within standard (%)ManchesterEast CheshireStockportCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)80.0681.0883.2177.2579.32
    31-day treatment (96%)92.5496.3097.3995.7192.50
    62-day referral to treatment (85%)72.8553.4174.6776.2371.16
    Diagnostic waits over 6 weeks (%)ManchesterEast CheshireStockportEngland
    MRI11.6826.621.4121.40
    CT14.6611.492.939.92
    Echocardiography4.9126.2417.4628.48
    Colonoscopy4.5110.855.5330.83
    Gastroscopy29.3510.255.3129.02
    All 15 DM01 tests8.9816.1714.0823.14
    Community services activityCheshire East residentsCheshire and Merseyside ICB
    Care contacts72,825541,280
    Referrals18,28097,150
    Patients with a contact21,910146,240

    Community services (residents of Cheshire East), Jun 2026 (provisional). In June 2026, provisional Community Services Dataset records show that 60.8% of community contacts for Cheshire East residents (44,295 of 72,825 contacts) involved adults aged 65+. Borough activity reflects broader community provider activity rather than PCN delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access varies by 36.1 pp and overall good experience by 18.2 pp

    In 2025/26, overall QOF achievement ranged from 58.7% at David Lewis Medical Practice and 86.3% at Wilmslow Health Centre to 100.0% at Chelford Surgery against England's 92.5%. Vaccination and immunisation achievement varied by 100 pp, from 0.0% at David Lewis Medical Practice to 100.0% at Chelford Surgery (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Chelford Surgery1170.085.5%75.8%99.4%
    Alderley Edge1110.091.1%79.5%97.8%
    David Lewis100.0——97.2%
    Handforth12214.483.6%73.0%96.1%
    Kenmore1110.058.4%64.5%90.2%
    Wilmslow843.255.0%61.7%81.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire East (LAD)AssetPCNCheshire East (LAD)
    Care homes (catchment)20 (1,247 beds)n/aSchools (catchment)50n/a
    Children's centres114Places of worship55272
    Libraries416Day centres (VCS)11
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)1141Primary academies1178
    Special schools15

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory annual review recall

    Asthma reviews are 61.2% (England 65.7%; fell 6.0% over 2023 to 2025 vs England +4.4%), leaving 1,214 of 3,131 patients unreviewed; COPD reviews fell 5.2% to 75.0% across 663 patients. For discussion: run single-template respiratory recall with after-school and holiday slots, prioritising high-deprivation cohorts. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined SMI physical health check outreach

    Across 398 SMI patients, blood pressure checks fell 3.4 pp over 2023 to 2025 to 78.0% (England +4.4 pp to 83.4%), alcohol recording is 71.9% (England 81.8%) and BMI is 76.8% (England 82.1%). For discussion: introduce single-visit physical health checks and raise shared-care coding reconciliation with mental health partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pre-school MMR2 and booster recall

    In Q1 2025/26 across 135 five-year-olds, 4-in-1 coverage was 86.7% (below the 95.0% target by 8.3 pp) and MMR2 (91.1%) trailed MMR1 (96.3%) by 5.2 pp; 6-in-1 was 87.3% across 118 infants. For discussion: audit age-5 lists for children missing MMR2 or 4-in-1 boosters and offer catch-up clinics. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Anticipatory frailty capacity planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older adult blood pressure reviews (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood booster recall outreach (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Combined SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · Pre-school MMR2 and booster recall (p12)4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 · 6-in-1 coverage at 12 months · MMR dose 1 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15